Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort

Authors

Judith-Anne W. Chapman, Queen's University - Kingston, Ontario
Torsten O. Nielsen, University of British Columbia
Matthew J. Ellis, Washington University School of Medicine in St. LouisFollow
Phillip Bernard, University of UtahFollow
Stephen Chia, BCCA
Karen A. Gelmon, BCCA
Kathleen I. Pritchard, University of Toronto
Aurelie Le Maitre, Queen's University - Kingston, Ontario
Paul E. Goss, Massachusetts General Hospital
Samuel Leung, University of British Columbia
Lois E. Shepherd, Queen's University - Kingston, Ontario
Vivien H.C Bramwell, University of Calgary

Journal

Breast Cancer Research

Publication Date

2013

Volume

15

Issue

4

Inclusive Pages

R71

Document Type

Open Access Publication

Rights and Permissions

Chapman et al. Breast Cancer Research 2013, 15:R71 http://breast-cancer-research.com/content/15/4/R71

Recommended Citation

Chapman, Judith-Anne W.; Nielsen, Torsten O.; Ellis, Matthew J.; Bernard, Phillip; Chia, Stephen; Gelmon, Karen A.; Pritchard, Kathleen I.; Le Maitre, Aurelie; Goss, Paul E.; Leung, Samuel; Shepherd, Lois E.; and Bramwell, Vivien H.C, "Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort." Breast Cancer Research. 15, 4. R71. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1848